Insider filing · SGMT
George Kemble
Executive Chairman
profile →
Sagimet Biosciences Inc.
SGMT · Healthcare · 6 filings in 24 months
ticker →
George Kemble sold $3.6M of Sagimet Biosciences (SGMT)
Executed Aug 14, disclosed Aug 17, 3 days later.
Value, as filed
$3.6M
350,987 sh × $10.23
Executed
Aug 14
the trade date, as filed
Disclosed
Aug 17
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GKGeorge Kemble (Executive Chairman) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Sagimet Biosciences Inc. (SGMT). The largest single filing was $3.6M of SGMT (350,987 sh × $10.23, as filed), executed Aug 14.
The name
SGMTHealthcare · Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by George Kemble in SGMT
SGMTSALE
Sagimet Biosciences Inc.
$201K20,206 sh × $9.95
Exec Aug 11
Filed Aug 12 · 7:41 PM ET SGMTSALE Sagimet Biosciences Inc. $141K
18,844 sh × $7.46
Exec Jul 20
Filed Jul 22 · 4:05 PM ET SGMTSALE Sagimet Biosciences Inc. $290K
37,688 sh × $7.69
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET